Lai JI - Search Results

1

Concordance of Targeted Sequencing from Circulating Tumor DNA and Paired Tumor Tissue for Early Breast Cancer.

Huang CC, Tsai YF, Liu CY, Lien PJ, Lin YS, Chao TC, Feng CJ, Chen YJ, Lai JI, Cheng HF, Chen BF, Hsu CY, Chiu JH, Tseng LM. Huang CC, et al. Among authors: lai ji. Cancers (Basel). 2023 Sep 8;15(18):4475. doi: 10.3390/cancers15184475. Cancers (Basel). 2023. PMID: 37760445 Free PMC article.

2

Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers.

Huang CC, Tsai YF, Liu CY, Lien PJ, Lin YS, Chao TC, Feng CJ, Chen YJ, Lai JI, Phan NN, Hsu CY, Chiu JH, Tseng LM. Huang CC, et al. Among authors: lai ji. Ann Surg Oncol. 2022 Jun;29(6):3578-3590. doi: 10.1245/s10434-022-11347-0. Epub 2022 Feb 28. Ann Surg Oncol. 2022. PMID: 35226219

3

A generational comparison for unfavorable cancer of unknown primary in a single institute over 20 years.

Tang CY, Hang JF, Hung YP, Chiu NC, Lai JI, Chen MH, Liu CY, Yang MH, Chao Y, Chang PM. Tang CY, et al. Among authors: lai ji. Cancer Med. 2023 Jan;12(2):1090-1101. doi: 10.1002/cam4.4960. Epub 2022 Jul 3. Cancer Med. 2023. PMID: 35781808 Free PMC article.

4

CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer.

Lin CY, Yu CJ, Liu CY, Chao TC, Huang CC, Tseng LM, Lai JI. Lin CY, et al. Among authors: lai ji. Clin Transl Oncol. 2022 Nov;24(11):2120-2135. doi: 10.1007/s12094-022-02881-0. Epub 2022 Aug 2. Clin Transl Oncol. 2022. PMID: 35917055

5

[No title available]

[No authors listed] [No authors listed] PMID: 36042100

6

Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer.

Lin CY, Yu CJ, Liu CY, Chao TC, Huang CC, Tseng LM, Lai JI. Lin CY, et al. Among authors: lai ji. Clin Transl Oncol. 2022 Nov;24(11):2251-2253. doi: 10.1007/s12094-022-02928-2. Clin Transl Oncol. 2022. PMID: 36087247 No abstract available.

7

IKZF3 amplification frequently occurs in HER2-positive breast cancer and is a potential therapeutic target.

Lin CY, Yu CJ, Shen CI, Liu CY, Chao TC, Huang CC, Tseng LM, Lai JI. Lin CY, et al. Among authors: lai ji. Med Oncol. 2022 Sep 30;39(12):242. doi: 10.1007/s12032-022-01812-x. Med Oncol. 2022. PMID: 36180600

8

A systemic review of taxanes and their side effects in metastatic breast cancer.

Lai JI, Chao TC, Liu CY, Huang CC, Tseng LM. Lai JI, et al. Front Oncol. 2022 Oct 11;12:940239. doi: 10.3389/fonc.2022.940239. eCollection 2022. Front Oncol. 2022. PMID: 36303832 Free PMC article.

9

The association of trastuzumab with atrial fibrillation and heart failure in breast cancer patients in routine clinical practice: a population-based propensity score matching and competing risk model analysis.

Wu WC, Huang CC, Tsai YF, Lin YS, Feng CJ, Chen YJ, Lai JI, Chao TC, Liu CY, Tseng LM. Wu WC, et al. Among authors: lai ji. Breast Cancer Res Treat. 2023 Feb;198(1):113-122. doi: 10.1007/s10549-022-06753-7. Epub 2022 Dec 31. Breast Cancer Res Treat. 2023. PMID: 36586037 Free PMC article.

10

Regorafenib induces damage-associated molecular patterns, cancer cell death and immune modulatory effects in a murine triple negative breast cancer model.

Tseng LM, Lau KY, Chen JL, Chu PY, Huang TT, Lee CH, Wang WL, Chang YY, Huang CT, Huang CC, Chao TC, Tsai YF, Lai JI, Dai MS, Liu CY. Tseng LM, et al. Among authors: lai ji. Exp Cell Res. 2023 Aug 1;429(1):113652. doi: 10.1016/j.yexcr.2023.113652. Epub 2023 May 18. Exp Cell Res. 2023. PMID: 37209991 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page